Q MEDICAL TECHNOLOGIES LTDActive

Company number 05339771Private limited companyIncorporated 2005

Key figures

£2,341,280-6.7%
Net assets 2024/25
+0.6%
Average annual growth 2020/21–2024/25
01 m2 m3 m2020/212021/222022/232023/242024/25

Like most small UK companies, Q MEDICAL TECHNOLOGIES LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
02.5 m5 m7.5 m2020/212021/222022/232023/242024/25
Filed accounts2020/21–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand540,050417,41684,820365,98737,372
Total assets4,990,2285,332,0897,109,5505,612,9245,237,061
Total liabilities2,700,3503,048,800—3,090,7412,888,867
Net assets / total equity2,285,9332,281,9392,561,5562,509,5282,341,280
Average number of employees232216140

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: Q MEDICAL TECHNOLOGIES LTD

Company

Q MEDICAL TECHNOLOGIES LTD is a private limited company registered with Companies House under company number 05339771. It was incorporated on 24 Jan 2005. Its status is active. The registered office is in Kendal (LA8). Its nature of business (SIC 2007) is other human health activities (86900).

Accounts

The latest accounts in the database are for 2024/25 (period ending 28 Feb 2025); the company files small company accounts (filleted). Net assets were £2,341,280, down 6.7% on the previous year. Cash at bank and in hand was £37,372. Total assets were £5,237,061 and total liabilities £2,888,867. The company had an average of 0 employees. Figures are available for 5 financial years (2020/21–2024/25).

Control and charges

The company has 1 current director. One person with significant control is registered.

Filing deadlines

The next accounts are due by 30 Nov 2026. The next confirmation statement is due by 7 Feb 2027.